Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
2002 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.
Gaspoz JM, Coxson PG, Goldman PA, Williams LW, Kuntz KM, Hunink MG, Goldman L. Gaspoz JM, et al. N Engl J Med. 2002 Jun 6;346(23):1800-6. doi: 10.1056/NEJM200206063462309. N Engl J Med. 2002. PMID: 12050341 Free article.
Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease.
Goldman L, Weinstein MC, Goldman PA, Williams LW. Goldman L, et al. JAMA. 1991 Mar 6;265(9):1145-51. JAMA. 1991. PMID: 1899896
Cost-effectiveness considerations in the treatment of heterozygous familial hypercholesterolemia with medications.
Goldman L, Goldman PA, Williams LW, Weinstein MC. Goldman L, et al. Am J Cardiol. 1993 Sep 30;72(10):75D-79D. doi: 10.1016/0002-9149(93)90015-5. Am J Cardiol. 1993. PMID: 8213502